Symptomatic hypocalcemia after intravenous pamidronate

Journal of Palliative Care

Volumn 12, Issue 1, 1996, Pages 46-47

  Mcintyre, Evelyn ^a   Bruera, Eduardo ^a  

^a Edmonton General Hospital   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; PAMIDRONIC ACID;

AGED; ARTICLE; BLADDER TUMOR; CANADA; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; HUMAN; HYPERCALCEMIA; HYPOCALCEMIA; INTRAVENOUS DRUG ADMINISTRATION; TRANSITIONAL CELL CARCINOMA;

AGED; ALBERTA; CARCINOMA, TRANSITIONAL CELL; DIPHOSPHONATES; FEMALE; HUMANS; HYPERCALCEMIA; HYPOCALCEMIA; INFUSIONS, INTRAVENOUS; URINARY BLADDER NEOPLASMS;

EID: 0030093323     PISSN: 08258597     EISSN: None     Source Type: Journal    
DOI: 10.1177/082585979601200109     Document Type: Article

References (9)

1. Folstein MF, Folstein S, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psych Res 1975; 12: 189-198.
2. Harrison's Principles of Internal Medicine, 11th Edition. New York: McGraw-Hill Book Company, 1987; 1874.
3. Physicians Drug Handbook, 5th Edition. Springhouse, Pennsylvania: Springhouse Corporation, 1993; 824.
4. Purohit OP, Anthony C, Radstone CR, et al. High-dose intravenous pamidronate for metastatic bone pain. Br J Cancer. 1994; 70(3): 554-558.
5. Pedersen-Bjergaard U, Myhre J. Severe hypocalcemia (corrected) after treatment with disphosphonate and aminoglycoside (Letter). Br Med J 1990; 302(6779): 791.
6. Bondiau PY, Peyrade F, Creisson A, et al. Severe hypocalcemia after treatment with bisphosphonates and aminoglycoside (Letter). Presse Medicale 1994; 23(17): 816.
7. Mayordomo JI, Rivera F. Severe hypocalcemia after treatment with oral clodronate and aminoglycoside (Letter). Ann Oncology 1993; 4(5): 432-433.
8. Jodrell DJ, Iveson TJ, Smith IE. Symptomatic hypocalcemia after treatment with high-dose aminohydroxypropylidene disphosphonate. Lancet 1987; i: 622.
9. Rotstein S, Glass U, Eriksson M, et al. Intravenous clodronate for the treatment of hypercalcemia in breast cancer patients with bone metastases - a prospective randomized placebo-controlled multicenter study. Eur J Cancer 1992; 28A(4-5): 890-893.